HIV drug exposure in womb may increase child risk of microcephaly, developmental delays

Children born to women on HIV therapy containing the drug efavirenz were 2 to 2.5 times more likely to have microcephaly, or small head size, compared to children born to women on regimens of other antiretroviral drugs, according to a new analysis. The children with microcephaly also had a higher risk for developmental delays, compared to children with normal head size.

From http://besthealthnews.com/2019/11/hiv-drug-exposure-in-womb-may-increase-child-risk-of-microcephaly-developmental-delays/?utm_source=rss&utm_medium=rss&utm_campaign=hiv-drug-exposure-in-womb-may-increase-child-risk-of-microcephaly-developmental-delays

from
https://healthnews010.wordpress.com/2019/11/19/hiv-drug-exposure-in-womb-may-increase-child-risk-of-microcephaly-developmental-delays/